PETROS PHARMACEUTICALS INC.

Petros Pharmaceuticals' proprietary AI-integrated technology achieved success in 30 out of 31 consumer comprehension objectives, meeting FDA's thresholds for potential prescription to over-the-counter drug transitions.

Petros Pharmaceuticals completed a Formative Human Factors study for its AI-integrated Web App, aimed at facilitating over-the-counter access to Stendra (avanafil) for erectile dysfunction.

Petros Pharmaceuticals has successfully launched an AI tool integrated into its web app for patient self-screening, aiming to optimize the safe use of Stendra.